0001140361-18-027386.txt : 20180605 0001140361-18-027386.hdr.sgml : 20180605 20180605165818 ACCESSION NUMBER: 0001140361-18-027386 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180605 DATE AS OF CHANGE: 20180605 EFFECTIVENESS DATE: 20180605 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Qu Biologics Inc. CENTRAL INDEX KEY: 0001742632 IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-313935 FILM NUMBER: 18881918 BUSINESS ADDRESS: STREET 1: 305 - 4475 WAYBURNE DRIVE CITY: BURNABY STATE: A1 ZIP: V5G 4X4 BUSINESS PHONE: (604) 734-1450 MAIL ADDRESS: STREET 1: 305 - 4475 WAYBURNE DRIVE CITY: BURNABY STATE: A1 ZIP: V5G 4X4 D 1 primary_doc.xml X0708 D LIVE 0001742632 Qu Biologics Inc. 305 - 4475 WAYBURNE DRIVE BURNABY A1 BRITISH COLUMBIA, CANADA V5G 4X4 (604) 734-1450 BRITISH COLUMBIA, CANADA None None Corporation true Harold David Gunn 305 - 4475 Wayburne Drive Burnaby A1 BRITISH COLUMBIA, CANADA V5G 4X4 Executive Officer Director Simon Sutcliffe 305 - 4475 Wayburne Drive Burnaby A1 BRITISH COLUMBIA, CANADA V5G 4X4 Executive Officer Director Julia Levy 305 - 4475 Wayburne Drive Burnaby A1 BRITISH COLUMBIA, CANADA V5G 4X4 Director Robert E. Pelzer 305 - 4475 Wayburne Drive Burnaby A1 BRITISH COLUMBIA, CANADA V5G 4X4 Director Michael Leschuk 305 - 4475 Wayburne Drive Burnaby A1 BRITISH COLUMBIA, CANADA V5G 4X4 Director Alun Rees 305 - 4475 Wayburne Drive Burnaby A1 BRITISH COLUMBIA, CANADA V5G 4X4 Executive Officer Jim Pankovich 305 - 4475 Wayburne Drive Burnaby A1 BRITISH COLUMBIA, CANADA V5G 4X4 Executive Officer Gillian Vandermeirsch 305 - 4475 Wayburne Drive Burnaby A1 BRITISH COLUMBIA, CANADA V5G 4X4 Executive Officer Biotechnology Decline to Disclose 06b false 2018-05-24 true true true true true Units; each unit consists of 2 common shares and 1 common share purchase warrant false 0 77627 48811 28816 Aggregate offering includes amount that may be received by Issuer upon exercise of warrants; each warrant may be exercised for 1 common share at CDN$6.50 per share until June 30, 2022. false 1 0 0 0 false Qu Biologics Inc. /s/ Harold David Gunn Harold David Gunn Chief Executive Officer 2018-06-04